|
|
||||||||
Eur J Cardiothorac Surg 2002;21:514-519
© 2002 Elsevier Science NL
Department of Thoracic Surgery, University of Torino, San Giovanni Battista Hospital, v. Genova 3, 10126 Turin, Italy
Received 17 September 2001; received in revised form 5 December 2001; accepted 10 December 2001.
* Corresponding author. Tel.: +39-011-633-6775; fax: +39-011-696-0170
e-mail: ottavio.rena{at}tiscalinet.it
Objective: We review our results on surgical treatment of patients with stage I non-small cell lung carcinoma and we attempted to clarify the prognostic significance of some surgicalpathologic variables. Methods: From 1993 to 1999, 667 patients received curative lung resection and complete hilar and mediastinal lymphadenectomy for non-small cell lung cancer. Of these, there were 436 Stage I disease (65%), of whom 144 T1N0 and 292 T2N0. No patients had pre- or postoperative radio- or chemotherapy. Prognostic significance of the following independent variables was tested using univariate (log-rank) and multivariate (Cox proportional-hazards) analysis: type of resection (sublobar vs lobectomy vs pneumonectomy), histology (squamous cell vs adenocarcinoma), tumour size (
3 cm vs >3 cm), histologic vascular invasion, visceral pleura involvement, positive bronchial resection margin, general T status. Results: Overall 5-year survival was 63%. In both univariate and multivariate survival analysis, significant prognostic factors were histology (adenocarcinoma 65% vs squamous cell carcinoma 51%), tumour size (
3 cm 67% vs >3 cm 46%), and the presence of negative resection margin. Five-year survival by general T status was 66% in T1N0 vs 55% in T2N0 disease (P=0.19). Conclusions: Despite advances in early diagnosis and surgical technique, 5-year survival of stage I non-small cell lung carcinoma remains low as compared to survival of other solid organ neoplasm. Tumour size
3 cm, adenocarcinoma histologic type and negative bronchial resection margins were associated with a more favourable outcome in our patient population. More effective multimodality treatments are needed to increase survival rates.
Key Words: Early-stage non-small cell lung cancer Stage I non-small cell lung cancer Surgery
This article has been cited by other articles:
![]() |
O. Rena, L. Carsana, S. Cristina, E. Papalia, F. Massera, L. Errico, C. Bozzola, and C. Casadio Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 863 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-K. Hsu, H.-C. Huang, C.-C. Hsieh, H.-S. Hsu, Y.-C. Wu, M.-H. Huang, and W.-H. Hsu Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., December 1, 2007; 84(6): 1825 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Hsu, C.-S. Huang, H.-S. Hsu, W.-J. Huang, H.-C. Lee, B.-S. Huang, and M.-H. Huang Preoperative Serum Carcinoembryonic Antigen Level is a Prognostic Factor in Women With Early Non-Small-Cell Lung Cancer Ann. Thorac. Surg., February 1, 2007; 83(2): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riquet, C. Foucault, P. Berna, J. Assouad, A. Dujon, and C. Danel Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping Ann. Thorac. Surg., June 1, 2006; 81(6): 1988 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Flieder, J. L. Port, R. J. Korst, P. J. Christos, M. A. Levin, D. E. Becker, and N. K. Altorki Tumor Size Is a Determinant of Stage Distribution in T1 Non-Small Cell Lung Cancer Chest, October 1, 2005; 128(4): 2304 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Khan, J. J. Fitzgerald, M. L. Field, I. Soomro, F. D. Beggs, W. E. Morgan, and J. P. Duffy Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung Ann. Thorac. Surg., April 1, 2004; 77(4): 1173 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, M. S. Kent, R. J. Korst, D. Libby, M. Pasmantier, and N. K. Altorki Tumor Size Predicts Survival Within Stage IA Non-Small Cell Lung Cancer Chest, November 1, 2003; 124(5): 1828 - 1833. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |